Drug firms 'too heavily reliant on ageing sales portfolios'

"Last year, drug sales were at an all-time high of $856bn (£535bn), but only 5pc of those sales were driven by products launched within the last five years. The struggle companies face in reinvigorating their portfolios was illustrated by the number of "new molecular entities" launched last year dropping to 21, down from 26 in 2009. "

http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/8599643/Drug-firms-too-heavily-reliant-on-ageing-sales-portfolios.html